About this trial
This is a prospective multicenter multinational randomized control trial. The duration of the study for the individual patient will be approximately 1 year (pre-operative assessments, 1 week, 3 months and 12 months follow-up assessments). Participants will be randomized to one of two surgical approaches: eRW or CO, with a 1:1 allocation in a parallel design.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Individuals aged 18 years and older who have clinically established post-linguistic sensorineural hearing loss.
CI candidate based on local or national reimbursement criteria.
Cochlear implantation with a CI632.
Preoperative 500 Hz pure-tone air conduction threshold <80 dB hearing level (HL) in the ear to be implanted.
Disqualifiers
Previous or existing CI recipient.
Ossification or other anatomical abnormalities of the cochlea or its windows possibly affecting normal electrode array insertion.
Abnormal cochlear nerve anatomy on preoperative CT or MRI.
Subjects who are unable to undergo CT or MRI.
Trial design
Parallel
Treatments tested in this trial
Surgical approach: cochleostomy or extended round window
Procedure/SurgerySurgical placement of a cochlear implant electrode array
Treatment groups
Trial outcomes
Primary outcomes
Residual hearing
The difference in residual hearing per group (eRW or CO) between pre- and postoperative pure tone thresholds, averaged at 500, 750 and 1000 Hz (PTAlow).
Secondary outcomes
ECochG thresholds after multiple surgery stages
ECochG thresholds with a promontory recording electrode after the following surgery stages: a) posterior tympanotomy (baseline), b) drilling for RW membrane exposure, c) completion of the approach to implantation (CO or eRW), d) sheath insertion, e) electrode array insertion, f) sheath withdrawal, and g) positioning of the electrode lead.
Intracochlear electrode position
The position of electrode contacts relative to the modiolus and the angular insertion depth (AID), as assessed with pre- and post-operative CT-scan.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Radboud University Medical Center
Lead sponsor
GZA Ziekenhuizen Campus Sint-Augustinus
Collaborator
Universitaire Ziekenhuizen KU Leuven
Collaborator